Drug utilization analysis of oral hypoglycemic agents in our hospital during the period of 2003-2005

Diabetes mellitus(DM)is a normal lifelong chronic diseasethat is harmful to our health.The number of diabetic patients inthe world is 112 million in 1998 and it is presupposed to 300million according to the data published by the World Health Or-ganization(WHO)1].With the improvement of living standardand the development of aging population,more people are suffer-ing from this disease.Chinically.diabetes mellitus is classifiedinto two types,type 1 and type 2 diabetes mellitus or insulin-de-…

Drug utilization analysis of oral hypoglycemic agents in our hospital during the period of 20032005

Objective:To assess the drug utilization and tendency of progress of oral hypoglycemic agents in our hospital and to provide references for rational administration clinically.Methods:DDDs,sales quantities,sales expenses and the ratio of sales expenses sequencing to that of DDDs in our hospital during the period of 2003~2005 were analyzed statistically with the method of DDDs analysis.Results:The top two antidiabetic drugs according to DDDs were melbine (dimethyl diguanide) and gliclazide three successive years.The DDDs of acarbose increased dramatically.Which blood glucose regulatsry drugs ranked lower,the ratio of sales expenses sequencing to that of DDDs of glipizide and gliclazide controlled release pellets was equal or about,whereas that of rosiglitazone,acarbose (glucobay) and glimepiride was less than 1.Conclusion:The study shows that the drug utilization of oral hypoglycemic agents in our hospital is basically rational and is in accordance with the trend of advancement and drug therapeutic strategies of diabetes mellitus.